CoChat

Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis

Open access
Wekker, V, van Dammen, L, Koning, A, Heida, K Y, Painter, R C, Limpens, J, Laven, J S E, Roeters van Lennep, J E, Roseboom, T J, Hoek, A · 2020 · Human Reproduction Update

The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with cardiometabolic disease, but recent systematic reviews and meta-analyses of longitudinal studies that quantify these associations are lacking. OBJECTIVE AND RATIONALE: Is PCOS a risk factor for cardiometabolic disease? SEARCH METHODS: We searched from inception to September 2019 in MEDLINE and EMBASE using controlled terms (e.g. MESH) and text words for PCOS and cardiometabolic outcomes, including cardiovascular disease (CVD), stroke, myocardial infarction, hypertension (HT), type 2 diabetes (T2D), metabolic syndrome and dyslipidaemia. Cohort studies and case–control studies comparing the prevalence of T2D, HT, fatal or non-fatal CVD and/or lipid concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TGs) between women with and without PCOS of ≥18 years of age were eligible for this systematic review and meta-analysis. Studies were eligible regardless of the degree to which they adjusted for confounders including obesity. Articles had to be written in English, German or Dutch. Intervention studies, animal studies, conference abstracts, studies with a follow-up duration less than 3 years and studies with less than 10 PCOS cases were excluded. Study selection, quality assessment (Newcastle–Ottawa Scale) and data extraction were performed by two independent researchers. OUTCOMES: Of the 5971 identified records, 23 cohort studies were included in the current systematic review. Women with PCOS had increased risks of HT (risk ratio (RR): 1.75, 95% CI 1.42 to 2.15), T2D (RR: 3.00, 95% CI 2.56 to 3.51), a higher serum concentration of TC (mean difference (MD): 7.14 95% CI 1.58 to 12.70 mg/dl), a lower serum concentration of HDL-C (MD: −2.45 95% CI −4.51 to −0.38 mg/dl) and increased risks of non-fatal cerebrovascular disease events (RR: 1.41, 95% CI 1.02 to 1.94) compared to women without PCOS. No differences were found for LDL-C (MD: 3.32 95% CI −4.11 to 10.75 mg/dl), TG (MD 18.53 95% CI −0.58 to 37.64 mg/dl) or coronary disease events (RR: 1.78, 95% CI 0.99 to 3.23). No meta-analyses could be performed for fatal CVD events due to the paucity of mortality data. WIDER IMPLICATIONS: Women with PCOS are at increased risk of cardiometabolic disease. This review quantifies this risk, which is important for clinicians to inform patients and to take into account in the cardiovascular risk assessment of women with PCOS. Future clinical trials are needed to assess the ability of cardiometabolic screening and management in women with PCOS to reduce future CVD morbidity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humupd/dmaa029

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Flow chart of study inclusion for a systematic review and meta-analysis of long-term cardiometabolic disease risk in women with polycystic ovary syndrome.
Figure 1. Flow chart of study inclusion for a systematic review and meta-analysis of long-term cardiometabolic disease risk in women with polycystic ovary syndrome.CC BY-NC · PubMed Central
Figure 2. Forest plots and funnel plot for meta-analysis of hypertension and type 2 diabetes among women with PCOS compared to women without PCOS. (a) Forest plot for hypertension (HT); (b) Funnel plot for meta-analysis of HT; (c) Forest plot for and type 2 diabetes (T2D); (d) Funnel plot for meta-analysis of T2D. The dashed lines in the funnel plots indicate the aggregated point estimate for the corresponding meta-analysis.
Figure 2. Forest plots and funnel plot for meta-analysis of hypertension and type 2 diabetes among women with PCOS compared to women without PCOS. (a) Forest plot for hypertension (HT); (b) Funnel plot for meta-analysis of HT; (c) Forest plot for and type 2 diabetes (T2D); (d) Funnel plot for meta-analysis of T2D. The dashed lines in the funnel plots indicate the aggregated point estimate for the corresponding meta-analysis.CC BY-NC · PubMed Central
Figure 3. Forest plot for total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides (mg/dl) concentration among women with PCOS compared to women without PCOS. Forest plots for (a) total cholesterol (TC); (b) low-density lipoprotein cholesterol (LDL-C); (c) high-density lipoprotein cholesterol (HDL-C); (d) triglycerides (TG).
Figure 3. Forest plot for total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides (mg/dl) concentration among women with PCOS compared to women without PCOS. Forest plots for (a) total cholesterol (TC); (b) low-density lipoprotein cholesterol (LDL-C); (c) high-density lipoprotein cholesterol (HDL-C); (d) triglycerides (TG).CC BY-NC · PubMed Central
Figure 4. Forest plot for non-fatal coronary events, non-fatal cerebrovascular events, composite outcome for non-fatal cardiovascular disease events and composite outcomes for fatal and non-fatal cardiovascular disease events among women with PCOS compared to women without PCOS. Forest plots for (a) non-fatal coronary events; (b) non-fatal cerebrovascular events; (c) composite outcome for non-fatal cardiovascular disease events; (d) composite outcome for fatal cardiovascular disease events.
Figure 4. Forest plot for non-fatal coronary events, non-fatal cerebrovascular events, composite outcome for non-fatal cardiovascular disease events and composite outcomes for fatal and non-fatal cardiovascular disease events among women with PCOS compared to women without PCOS. Forest plots for (a) non-fatal coronary events; (b) non-fatal cerebrovascular events; (c) composite outcome for non-fatal cardiovascular disease events; (d) composite outcome for fatal cardiovascular disease events.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Research works printed but not linked: 1

  1. Zawadzki, 1992, Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach

Cited by

See all 450

Metadata

Authors
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
  • Ziekenhuis Amstelland (NL)
  • University Medical Center Utrecht (NL)
  • Amsterdam University Medical Centers (NL)
  • Erasmus MC (NL)
  • Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands
  • University Medical Center Groningen (NL)
Corresponding author
Wekker, V
Venue
Human Reproduction Update
Published
2020-09-30
Volume
26
Issue
6
Pages
942-960
ISSN
  • 1355-4786 (ISSN-L)
  • 1460-2369
OpenAlex
W3090224534
Cited by
425
References
71
Citations by year
2026: 80 · 2025: 89 · 2024: 76 · 2023: 89 · 2022: 48 · 2021: 39 · 2020: 3
FWCI
6.62
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction Update (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Funders
Dutch Heart Foundation (2013T085)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
polycystic ovary syndrome, cardiometabolic disease, cardiovascular disease, stroke, myocardial infarction, hypertension, type 2 diabetes, metabolic syndrome, dyslipidemia, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, women's health, long-term risk factors, cardiovascular risk stratification
MeSH terms
Cardiometabolic Risk Factors, Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Obesity, Polycystic Ovary Syndrome, Risk Factors, Triglycerides, Case-Control Studies, Stroke, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1093/humupd/dmaa029
The paper
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020). Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Human Reproduction Update. https://doi.org/10.1093/humupd/dmaa029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.